Nations Back Landmark Health Deal at Troubled UN Biodiversity Summit 04/11/2024 Stefan Anderson Nearly 200 nations have backed a groundbreaking global action plan linking health and the natural world at the close of UN biodiversity negotiations in Cali, Colombia, marking a rare victory in a summit otherwise characterised by disappointment. The final agreement on a “health and biodiversity action plan” was approved as a voluntary rather than mandatory […] Continue reading -> Nations Deadlocked Over Health-Biodiversity Framework at COP16 26/10/2024 Stefan Anderson Only 35 countries have submitted the national strategies required by the UN biodiversity treaty showing how they’ll meet its binding nature protection targets. While 33 of these plans recognise links between human health and biodiversity, they offer few specifics on implementation and policy, a Health Policy Watch analysis found. Negotiators in Cali aim to bridge […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Africa CDC Accuses US Government of Creating Panic in Travel Advisory Over Rwanda Marburg Outbreak 10/10/2024 Paul Adepoju The Africa CDC has slammed the US government’s recent Level 3 travel advisory for Rwanda as unfair and baseless, arguing it undermines Rwanda’s proactive efforts to contain a Marburg outbreak. With rapid testing, vaccinations, and coordinated emergency response measures in place, Rwanda’s leaders insist the country poses no international threat and warn that travel restrictions […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Alzheimer’s Advocates Urge G7 to Accelerate Research and Healthcare Preparedness 09/10/2024 Maayan Hoffman Helen Rochford-Brennan, a 72-year-old Irish woman living with Alzheimer’s, was first diagnosed at 57, with a more complete diagnosis following five years later. At the time, there were no life-enhancing medications, leaving her to face the grim reality of her brain’s gradual decline, enduring what she described as “many dark days.” “Imagine having a new […] Continue reading -> Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Nations Deadlocked Over Health-Biodiversity Framework at COP16 26/10/2024 Stefan Anderson Only 35 countries have submitted the national strategies required by the UN biodiversity treaty showing how they’ll meet its binding nature protection targets. While 33 of these plans recognise links between human health and biodiversity, they offer few specifics on implementation and policy, a Health Policy Watch analysis found. Negotiators in Cali aim to bridge […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Africa CDC Accuses US Government of Creating Panic in Travel Advisory Over Rwanda Marburg Outbreak 10/10/2024 Paul Adepoju The Africa CDC has slammed the US government’s recent Level 3 travel advisory for Rwanda as unfair and baseless, arguing it undermines Rwanda’s proactive efforts to contain a Marburg outbreak. With rapid testing, vaccinations, and coordinated emergency response measures in place, Rwanda’s leaders insist the country poses no international threat and warn that travel restrictions […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Alzheimer’s Advocates Urge G7 to Accelerate Research and Healthcare Preparedness 09/10/2024 Maayan Hoffman Helen Rochford-Brennan, a 72-year-old Irish woman living with Alzheimer’s, was first diagnosed at 57, with a more complete diagnosis following five years later. At the time, there were no life-enhancing medications, leaving her to face the grim reality of her brain’s gradual decline, enduring what she described as “many dark days.” “Imagine having a new […] Continue reading -> Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Africa CDC Accuses US Government of Creating Panic in Travel Advisory Over Rwanda Marburg Outbreak 10/10/2024 Paul Adepoju The Africa CDC has slammed the US government’s recent Level 3 travel advisory for Rwanda as unfair and baseless, arguing it undermines Rwanda’s proactive efforts to contain a Marburg outbreak. With rapid testing, vaccinations, and coordinated emergency response measures in place, Rwanda’s leaders insist the country poses no international threat and warn that travel restrictions […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Alzheimer’s Advocates Urge G7 to Accelerate Research and Healthcare Preparedness 09/10/2024 Maayan Hoffman Helen Rochford-Brennan, a 72-year-old Irish woman living with Alzheimer’s, was first diagnosed at 57, with a more complete diagnosis following five years later. At the time, there were no life-enhancing medications, leaving her to face the grim reality of her brain’s gradual decline, enduring what she described as “many dark days.” “Imagine having a new […] Continue reading -> Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa CDC Accuses US Government of Creating Panic in Travel Advisory Over Rwanda Marburg Outbreak 10/10/2024 Paul Adepoju The Africa CDC has slammed the US government’s recent Level 3 travel advisory for Rwanda as unfair and baseless, arguing it undermines Rwanda’s proactive efforts to contain a Marburg outbreak. With rapid testing, vaccinations, and coordinated emergency response measures in place, Rwanda’s leaders insist the country poses no international threat and warn that travel restrictions […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Alzheimer’s Advocates Urge G7 to Accelerate Research and Healthcare Preparedness 09/10/2024 Maayan Hoffman Helen Rochford-Brennan, a 72-year-old Irish woman living with Alzheimer’s, was first diagnosed at 57, with a more complete diagnosis following five years later. At the time, there were no life-enhancing medications, leaving her to face the grim reality of her brain’s gradual decline, enduring what she described as “many dark days.” “Imagine having a new […] Continue reading -> Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Alzheimer’s Advocates Urge G7 to Accelerate Research and Healthcare Preparedness 09/10/2024 Maayan Hoffman Helen Rochford-Brennan, a 72-year-old Irish woman living with Alzheimer’s, was first diagnosed at 57, with a more complete diagnosis following five years later. At the time, there were no life-enhancing medications, leaving her to face the grim reality of her brain’s gradual decline, enduring what she described as “many dark days.” “Imagine having a new […] Continue reading -> Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Alzheimer’s Advocates Urge G7 to Accelerate Research and Healthcare Preparedness 09/10/2024 Maayan Hoffman Helen Rochford-Brennan, a 72-year-old Irish woman living with Alzheimer’s, was first diagnosed at 57, with a more complete diagnosis following five years later. At the time, there were no life-enhancing medications, leaving her to face the grim reality of her brain’s gradual decline, enduring what she described as “many dark days.” “Imagine having a new […] Continue reading -> Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> Posts navigation Older postsNewer posts